BioSpace News Archive

Acceleron Pharma Inc. today announced that Habib Dable, President and Chief Executive Officer, will present an overview of the company along with its upcoming corporate priorities at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 2:00 p.m. PST / 5:00 p.m. EST in San Francisco, California.

Deciphera Pharmaceuticals, Inc. today announced that Michael D. Taylor, Ph.D., President and Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at 2:00 PM PT at the Westin St. Francis in San Francisco.

PathMaker Neurosystems Inc. has appointed Jean-Luc Boulnois, E.M.B.A, Ph.D., to the Company’s Board of Directors. Dr. Boulnois has over 30 years of international leadership experience in creating, operating, and financing medical device companies, with which he led several mergers, acquisitions, and financing rounds.

Previously Announced Call to Discuss Merger with CVie Therapeutics, $39 Million Private Placement, New Products Overview and Plans for 2019

Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that the company and its subsidiaries will present at upcoming investor conferences in San Francisco.

January 2 at 8:30 a.m. ET

DCC-3014, A Highly-Selective and Potent Small Molecule Inhibitor of CSF1R, Demonstrates Tolerability, Pharmacokinetics and Biomarker Mechanistic Proof-of-Concept (mPoC) in Patients with Advanced Malignancies

Luminex Corporation (NASDAQ: LMNX) today announced that the company has completed its previously announced acquisition of MilliporeSigma’s flow cytometry portfolio for $75 million in combined stock, asset and inventory purchases.

APRINOIA Therapeutics, a clinical-stage biotechnology company developing therapeutics and diagnostic imaging tools for neurodegenerative diseases announced today that it has entered into a non-exclusive licensing agreement with Celgene Corporation.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019, at 4:00 p.m.